Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-050149

SVP & Chief Financial Officer sold 25,000 shares at $20.52 ($513,000)

  • SVP & Chief Financial Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP & Chief Financial Officer 2019-09-16 Option exercise +25,000 $7.21 $180,250 177,872 D
Labrucherie Gil M SVP & Chief Financial Officer 2019-09-16 Sale −25,000 $20.52 $513,000 152,872 D
Derivatives
Labrucherie Gil M SVP & Chief Financial Officer 2019-09-16 Option exercise · Stock Option −25,000 50,000 D
Open-market sales · 25,000 sh · avg $20.52 · $513,000
Loading xslF345X03/doc4.xml…